NOVARTIS SINGAPORE PHARMACEUTICAL MANUFACTURING PTE. LTD. is the Singapore biopharmaceutical manufacturing arm of Novartis AG, one of the world's leading innovative medicines companies. Located in Tuas Biomedical Park, the facility manufactures biologic medicines, therapeutic antibodies, and advanced pharmaceutical products for global markets. The site is one of Novartis' key biologics manufacturing facilities in Asia and leverages advanced automation, digital manufacturing, and sustainable production technologies. In 2024, Novartis announced a US$256 million expansion of the facility to increase biologics manufacturing capacity and create approximately 100 highly skilled jobs in Singapore.